Skip to main content

Toxische Hepatosen

Medikamentöse und gewerbetoxische Leberschäden

  • Chapter
  • 120 Accesses

Part of the book series: Spezielle pathologische Anatomie ((SPEZIELLE,volume 10))

Zusammenfassung

Umweltstoffe, gewerbliche Toxine, häusliche und pflanzliche Gifte und schließlich Medikamente bergen Risiken seit alters, und in neuerer Zeit gesellen sich Verunreinigungen von Luft, Wasser und Nahrung hinzu. Die meisten dieser Stoffe und Medikamente insbesondere, treffen vornehmlich und zuerst die Leber als das wesentliche Stoffwechselorgan. Um immer möglichen Schädigungen zu begegnen, hat man sich gewöhnt, jedenfalls die industriellen und pharmakologisch definierten Substanzen auf ihre Toxizität zu überprüfen, im Tierversuch zu testen und — nach ihrer Freigabe — auf unerwartete Wirkungen und Nebenwirkungen besonders zu achten. Trotz alledem sind wir häufig nicht in der Lage, selbst schwere Leberschäden innerhalb einzelner Subpopulationen vorauszusagen, sie, wo sie einmal auftreten, hinreichend rasch zu entdecken und — nach einem Zwischenfall — jeweils einvernehmlich zu klären, was genau sich ereignet, welche abnorme Reaktion stattgefunden hat. Zweifellos wird sich daran auch zukünftig nichts Entscheidendes ändern können; dies umso weniger angesichts einer offenbar zunehmenden Neigung zu Selbstbehandlung, womöglich mit undeklarierten pflanzlichen Zubereitungen (Georgii et al. 1988; Perharic Walton u. Murray 1992; Kane et al. 1995; Larrey u. Pageaux 1995), wodurch es im Ernstfall vollends ausgeschlossen ist, brauchbare Übersicht zu gewinnen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alpert LI (1976) Veno-occlusive disease of the liver associated with oral contraceptives. Hum Pathol 7:709–718

    Article  PubMed  CAS  Google Scholar 

  • Altmann H-W (1976) Morphologie der alkoholbedingten Leberschaden. In: Kühn HA, Wernze H (Hrsg) Klinische Hepatologie. Thieme, Stuttgart, S 6.120–6.132

    Google Scholar 

  • Altmann H-W (1980a) Drug-induced liver reactions: a morphological approach. Curr Top Pathol 69:69–142

    PubMed  CAS  Google Scholar 

  • Altmann H-W (1980b) Die granulomatosen Reaktionen der Leber. Verh Dtsch Ges Pathol 64:152–177

    PubMed  CAS  Google Scholar 

  • Altmann H-W (1990) Onkozytare Hepatozyten. Pathologe 11:137–142

    PubMed  CAS  Google Scholar 

  • Altmann H-W (1994) Hepatic neoformations. Pathol Res Pract 190:513–577

    PubMed  CAS  Google Scholar 

  • Arn PH, Hauser ER, Thomas GH, Herman G, Hess D, Brusilow SW (1990) Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. N Engl J Med 322:1652–1655

    Article  PubMed  CAS  Google Scholar 

  • Bagheri SA, Boyer JL (1974) Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury. Ann Intern Med 81:610–618

    PubMed  CAS  Google Scholar 

  • Le Bail B, Jouhanole H, Deugnier Y, Salame G, Pellegrin J-L, Saric J et al. (1992) Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol 16:982–987

    Article  PubMed  Google Scholar 

  • Balasz M (1988) Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases. Exp Pathol 35:231–237

    Google Scholar 

  • Balistreri WF, Bove KE (1990) Hepatobiliary consequences of parenteral alimentation. In: Popper H, Schaffner F (eds) Progress in liver disease, vol IX. WB Saunders, Philadephia, pp 567–601

    Google Scholar 

  • Ballardini G, Fallani M, Biagini G, Bianchi FB, Pisi E (1988) Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B 56:45–49

    Article  PubMed  CAS  Google Scholar 

  • Bannasch P (1990) Pathobiology of chemical hepatocarcinogenesis: recent progress and perspectives. 1. Cytomorphological changes and cell proliferation. J Gastroenterol Hepatol 5:149–159

    Article  PubMed  CAS  Google Scholar 

  • Bannasch P, Bloch M, Zerban H (1981) Spongiosis hepatis: specific changes of the perisinusoidal liver cells induced in rats by N-Nitrosomorpholine. Lab Invest 44:252–264

    PubMed  CAS  Google Scholar 

  • Barcley KL, Yeong ML (1994) Actinomycin D-associated hepatic venoocclusive disease — a report of two cases. Pathology 26:257–260

    Article  Google Scholar 

  • Barone P, Inferrera C (1969) Pigments in the Dubin-Johnson syndrome. In: Wolman M (ed) Pigments in pathology. Academic Press, New York, pp 307–325

    Google Scholar 

  • Barthel HR, Hiepe F (1995) Lupus erythematodes und Lebererkrankungen. Dtsch Med Wochenschr 120:1253–1257

    Article  PubMed  CAS  Google Scholar 

  • Bénichou C (1990) Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 11:272–276

    Article  PubMed  Google Scholar 

  • Berneau J, Mallet L, Benhamou JP (1981) Hepatotoxicite due a la acide tielique. Gastroenterol Clin Biol 5:692–693

    Google Scholar 

  • Le Bihan G, Bourreille J, Sampson M, Leroy J, Szekely AM, Coquerel A (1980) Fatal hepatic failure and sodium valproate. Lancet 11:1298–1299

    Article  Google Scholar 

  • Binek J, Hany A, Egloff B, Heer M (1991) Akute todliche Leberinsuffizienz unter Valproinsäuretherapie. Schweiz Med Wochenschr 121:228–233

    PubMed  CAS  Google Scholar 

  • Bioulac-Sage P, Le Bail B, Bernard PH, Balabaud C (1995) Hepatoportal sclerosis. Semin Liver Dis 15:329–339

    Article  PubMed  CAS  Google Scholar 

  • Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR (1975) Isoniacid-associated hepatitis in 124 patients. Gastroenterology 69:289–302

    PubMed  CAS  Google Scholar 

  • Blake JC, Sawyerr AM, Dooley JS, Scheuer PJ, McIntyre N (1990) Severe hepatitis caused by cyproterone acetate. Gut 31:556–557

    Article  PubMed  CAS  Google Scholar 

  • Böhles H (1986) Cholestase bei totaler parenteraler Ernahrung (TPE) — eine Übersicht. Klin Paediatr 198:435–441

    Article  Google Scholar 

  • Bolton JS, Bowen JC (1986) Biliary sclerosis associated with hepatic artery infusion of floxuridine. Surgery 99:119–122

    PubMed  CAS  Google Scholar 

  • Bourdi M, Larrey D, Nataf J, Berneau J, Pessayre D, Iwasaki M et al. (1990) Anti-liver endoplasmatic reticulum autoantibodies are directed against human cytochrome P450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest 85:1967–1973

    Article  PubMed  CAS  Google Scholar 

  • Bower RH (1983) Hepatic complications of parenteral nutrition. Semin Liver Dis 3:216–224

    Article  PubMed  CAS  Google Scholar 

  • Bras G (1973) Aspects of hepatic vascular diseases. In: Gall EA, Mostofi FK (eds) The liver. Williams & Wilkins, Baltimore, pp 406–430

    Google Scholar 

  • Le Bricquir Y, Larrey D, Blanc P, Pageaux GP, Michel H (1994) Tianeptine — an instance of druginduced hepatotoxicity predicted by prospective experimental studies. J Hepatol 21:771–773

    Article  PubMed  Google Scholar 

  • Brouwer A, Hendriks HFJ, Brekelmans P, Buitjenhek M, Knook DL (1986) Lipid analysis of different types of isolated liver cells and their lipid droplets. In: Kirn A, Knook DL, Wisse E (eds) Cells of the hepatic sinusoid, vol 1. Proceedings of the Third International Kupffer Cell Symposium held in Strasbourg, France, 23-27 September, 1985. The Kupffer Cell Foundation, Rijswijk, pp 175–180

    Google Scholar 

  • Brown RE, Ishak KG (1976) Hepatic zonal degeneration and necrosis in Reye syndrome. Arch Pathol Lab Med 100:123–126

    PubMed  CAS  Google Scholar 

  • Bruppacher R (1995) Epidemiological identification and evaluation of hepatic adverse drug reactions. Semin Liver Dis 15:301–308

    Article  PubMed  CAS  Google Scholar 

  • Callea F, Vos RB de, Togni R, Tardanico R, Vanstapel MJ, Desmet VJ (1986) Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization. Histopathology 10:65–73

    CAS  Google Scholar 

  • Chang C-H, Uchwat F, Masalskis F, Arcinue EL (1985) Morphologic grading of hepatic mitochondrial alterations in Reye’s syndrome: potential prognostic implication. Pediatr Pathol 4:265–275

    Article  PubMed  CAS  Google Scholar 

  • Chen KTK, Bocian JJ (1983) Multiple hepatic adenomas. Arch Pathol Lab Med 107:274–275

    PubMed  CAS  Google Scholar 

  • Clark DW (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drug 29:342–375

    Article  CAS  Google Scholar 

  • Coates PM, Stanley CA (1992) Inherited disorders of mitochondrial fatty oxidation. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol X. WB Saunders, Philadelphia, pp 123–138

    Google Scholar 

  • Combes B, Whalley PJ, Adams RH (1972) Tetracycline and the liver. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol IV. Grune & Stratton, New York, pp 589–596

    Google Scholar 

  • Correy L, Rubin RJ, Hattwick MAW, Nolle GR, Cassidy E (1976) A nationwide outbreak of Reye’s syndrome. Its epidemiologic relationship to influenca B. Am J Med 61:615–625

    Article  Google Scholar 

  • Cortez Pinto H, Baptista A, Camilo ME, de Cowsta EB, Valente A, de Moura MC (1995) Tamoxifenassociated steatohepatitis — report of three cases. J Hepatol 23:95–97

    Article  PubMed  CAS  Google Scholar 

  • Craig JR, Peters RL, Edmondson HA, Omata M (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46:372–379

    Article  PubMed  CAS  Google Scholar 

  • Craig JR, Peters RL, Edmondson HA (1988) Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, 2nd series, vol 26. Armed Forces Institute of Pathology, Washington

    Google Scholar 

  • Creagh TM, Rubin A, Evans DJ (1988) Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol 41:441–443

    Article  PubMed  CAS  Google Scholar 

  • Daly AK, Idle JR (1993) Genetics: animal and human cytochrome P450 polymorphism. In: Schenkmann JB, Grain H (eds) Handbook of experimental pharmacology, vol 105. Springer, Berlin Heidelberg New York Tokyo, pp 433–446

    Google Scholar 

  • Dargel R (1992) Lipid peroxidation — a common pathogenetic mechanism? Exp Toxicol Pathol 44:169–181

    PubMed  CAS  Google Scholar 

  • Daugherty CC, Gartside PS, Heubi JE, Saalfeld K, Snyder J (1987) A morphometric study of Reye’s syndrome. Correlation of reduced mitochondrial numbers and increased mitochondrial size with clinical manifestations. Am J Pathol 129:313–326

    PubMed  CAS  Google Scholar 

  • Davis BH, Vucic A (1988) The effects of retinol on Ito cell proliferation in vitro. Hepatology 8:788–793

    Article  PubMed  CAS  Google Scholar 

  • Degott C, Rueff B, Kreis H, Duboust A, Potet F, Benhamou JP (1978) Peliosis hepatis in recipients of renal transplants. Gut 19:748–753

    Article  PubMed  CAS  Google Scholar 

  • Dejgaard A, Krogsgaard K, Jacobsen M (1984) Veno-occlusive disease and peliosis of the liver after thorotrast administration. Virchows Arch A 403:87–92

    Article  CAS  Google Scholar 

  • Deleve LD, Kaplowitz N (1990) Importance and regulation of hepatic glutathione. Semin Liver Dis 10:251–266

    Article  PubMed  CAS  Google Scholar 

  • Del-Val A, Garrigues V, Ponce J, Benages R (1991) Glibenclamideinduced cholestasis. J Hepatol 13:375

    Article  PubMed  CAS  Google Scholar 

  • Denkhas W, Siebald H (1991) Toxische Leberschadigungen. In: Konietzko J, Dupuis H (Hrsg) Handbuch der Arbeitsmedizin. Arbeitsphysiologie — Arbeitspathologie — Prevention (5. Erg. Lief.). Ecomed, Landsberg/Lech

    Google Scholar 

  • Desmet VJ (1992) Vanishing bile duct disorders. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol X. WB Saunders, Philadelphia, pp 89–121

    Google Scholar 

  • Dias-Rivera RS, Collago PJ, Pous ER, Torregrosse MV (1950) Acute phosphoric poisoning in man: a study of 56 cases. Medicine 29:269–298

    Google Scholar 

  • Disney TF, Sullivan SN, Haddard RC, Lowe D, Goldbach MM (1984) Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus. J Clin Gastroenterol 6:253–256

    PubMed  CAS  Google Scholar 

  • Ditzhuijsen TJM van, Haelst UJGM van, Dooren-Grebe RJ van, Kerkhof PCM van de, Yap SH (1990) Severe hepatotoxicity reaction with progression to cirrhosis after use of a novel retinoid (acitretin). J Hepatol 11:185–188

    Article  PubMed  Google Scholar 

  • Dölle W, Martini WA (1978) Leber. In: Heintz R (Hrsg) Erkrankungen durch Arzneimittel. Diagnostik, Klinik, Pathogenese, Therapie, 2. Aufl. Thieme, Stuttgart, S 288–329

    Google Scholar 

  • Doppman JL, Girton ME (1984) Bile duct scarring following ethanol embolization of the hepatic artery: an experimental study in monkeys. Radiology 152:621–626

    PubMed  CAS  Google Scholar 

  • Dossing M, Arlien-Soborg P, Petersen LM, Ranek L (1983) Liver damage associated with occupational exposure to organic solvents in house painters. Eur J Clin Invest 13:151

    Article  PubMed  CAS  Google Scholar 

  • Dourakis SP, Alexopoulou AA, Hadziyannis SJ (1994) Fulminant hepatitis after flutamide treatment. J Hepatol 20:350–353

    Article  PubMed  CAS  Google Scholar 

  • Earnest DL, Brouwer A, Sim WW, Horan MA, Hendriks HFJ, Leeuw AM de, Knook DL (1986) Hypervitaminosis A activates Kupffer cells and lowers the threshold for endotoxin liver injury. In: Kirn A, Knook DL, Wisse E (eds) Cells of the hepatic sinusoid, vol 1. Proceedings of the Third International Kupffer Cell Symposium held in Strasbourg, France, 23-27 September, 1985. The Kupffer Cell Foundation, Rijswijk, pp 277–282

    Google Scholar 

  • Edmondson HA, Peters RL (1967) Diagnostic problems in liver biopsies. In: Sommers SC (ed) Pathology annual. Butterworth, London, pp 213–242

    Google Scholar 

  • Edmondson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86:180–186

    PubMed  CAS  Google Scholar 

  • Ehrenforth S, Scharrer I, Herrmann G (1995) Phenoprocoumon-induzierte nekrotisierende Hepatitis. Dtsch Med Wochenschr 120:1529–1530

    PubMed  CAS  Google Scholar 

  • Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y et al. (1995) Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis. Virchows Arch 426:95–101

    Article  PubMed  CAS  Google Scholar 

  • Evans DAP (1986) Acetylation. In: Kadow W, Goedde HW, Agarwal DP (eds) Ethnic differences in reactions of drugs and xenobiotics. Liss, New York, pp 209–242

    Google Scholar 

  • Falk H, Popper H, Thomas LB, Ishak KG (1979) Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 2:1120–1123

    Article  PubMed  CAS  Google Scholar 

  • Falk H, Caldwell G, Ishak KG, Thomas IB, Popper H (1981) Arsenic-related angiosarcoma. Am J Ind Med 2:43–50

    Article  PubMed  CAS  Google Scholar 

  • Fleischner GM, Morecki R, Hanaichi T, Hayashi M, Quintana H, Sternlieb I (1991) Light-and electron-microscopical study of a case of gold salt-induced hepatotoxicity. Hepatology 14:422–425

    Article  PubMed  CAS  Google Scholar 

  • Forbes GM, Jeffrey GP, Shilkin KB, Reed WD (1992) Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. Gastroenterology 102:1385–1388

    PubMed  CAS  Google Scholar 

  • Forns X, Caballeria J, Bruguera M, Salmeron JM, Vilella A, MAs A et al. (1994) Disulfiram-induced hepatitis. Report of four cases and review of the literature. J Hepatol 21:853–857

    Article  PubMed  CAS  Google Scholar 

  • Fox RA (1979) Immunological basis for toxic liver injury. In: Farber E, Fisher MM (eds) Toxic injury of the liver, part A. Marcel Dekker, New York Basel, pp 193–213

    Google Scholar 

  • Friefi G, Wienbeck M (1995) Cholestatischer Ikterus nach Einnahme von Amoxicillin und Clavulansaure. Dtsch Med Wochenschr 120:1356–1360

    Article  Google Scholar 

  • Frimmer M (1976) Mechanismus der Leberschadigung durch Pilzgifte. In: Wannagat L (Hrsg) Toxische Leberschaden. Thieme, Stuttgart, S 137–153

    Google Scholar 

  • Gaeta GB, Utili R, Tripodi MF (1986) The evaluation of drug hepatotoxicity should include the study of the Kupffer cell function. Comparative effects of Amphotericin B and Ketokonazole on the rat liver. In: Kirn A, Knook DL, Wisse E (eds) Cells of the hepatic sinusoid, vol 1. Proceedings of the Third International Kupffer Cell Symposium held in Strasbourg, France, 23-27 September, 1985. The Kupffer Cell Foundation, Rijswijk, pp 43–44

    Google Scholar 

  • Gascon MP, Dayer P (1992) Hepatic metabolism of drugs and toxins. In: McIntyre N, Benhamou JP, Bircher J, Rizetto M, Rodes J (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, pp 247–289

    Google Scholar 

  • Gedigk P, Muller R, Bechtelsheimer H (1974) Morphology of the liver damage among polyvinylchloride production workers. A report on 51 cases. Ann N Y Acad Sci 489:278–285

    Google Scholar 

  • Gedigk P, Totovic V (1976) Lysosomen und Pigmente. Verh Dtsch Ges Pathol 60:64–94

    Google Scholar 

  • Geerts A, Vrijsen R, Schellinck P, Wisse E (1989) Retinol affects the phenotype and protein synthesis of fat storing cell-derived myofibroblast in vitro. In: Wisse E, Knook DL, Decker K (eds) Cells of the hepatic sinusoid. Kupffer Cell Foundation, Rijswijk, pp 20–24

    Google Scholar 

  • Georgiou M, Sianidou L, Hatzis T, Paradatos J, Koutselinis A (1988) Hepatotoxicity due to Atractylis gummifera-L. Clin Toxicol 26:487–493

    Article  CAS  Google Scholar 

  • Gerber MA (1989) Pathology of acute and chronic hepatitis D. In: Seef LB, Lewis JH (eds) Current perspectives in hepatology: Festschrift for Hyman J Zimmerman. Plenum Press, New York, pp 63–70

    Google Scholar 

  • Gerber N, Dickinson RG, Harland RC, Lynn RK, Houghton D, Antonias JI, Schimschock JC (1979) Reye-like syndrome associated with valproic acid therapy. J Pediatr 95:142–144

    Article  PubMed  CAS  Google Scholar 

  • Geubel AP, Galoscy C de, Alves N, Rahier J, Dive C (1991) Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 100:1701–1709

    PubMed  CAS  Google Scholar 

  • Glassberg AB, Rosenbaum EH (1976) Oral contraceptives and malignant hepatoma. Lancet 2:479

    Article  Google Scholar 

  • Goldin R (1994) Rodent models of alcoholic liver disease. Int J Exp Pathol 75:1–7

    PubMed  CAS  Google Scholar 

  • Goldstein NS, Kodali VP, Gordon SC (1995) Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis. Am J Clin Pathol 104:567–573

    PubMed  CAS  Google Scholar 

  • Goodman ZD (1987) Benign tumours of the liver. In: Okuda K, Ishak KG (eds) Neoplasms of the liver. Springer, Berlin Heidelberg New York Tokyo, pp 105–125

    Google Scholar 

  • Goodman ZD, Mikel UV, Lubbers PR, Ros PR, Langloss JM, Ishak KG (1987) Kupffer cells in hepatocellular adenomas. Am J Surg Pathol 11:191–196

    Article  PubMed  CAS  Google Scholar 

  • Guengerich FP (1989) Polymorphismus of cytochrome P450 in humans. TIPS 10:107–109

    PubMed  CAS  Google Scholar 

  • Haemmerli UP (1966) Jaundice during pregnancy. With special emphasis on recurrent jaundice during pregnancy and its differential diagnosis. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Haemmerli UP, Wyss HI (1967) Recurrent intrahepatic cholestasis of pregnancy: report of six cases and review of the literature. Medicine 46:299–321

    Article  PubMed  CAS  Google Scholar 

  • Hirsch D, Bernheim J, Kovatz S, Shenkman L (1994) Fatal fulminant hepatitis from cyproterone acetate. Isr J Med Sci 30:238–240

    PubMed  CAS  Google Scholar 

  • Hohler T, Schnütgen M, Helmreich-Becker I, Mayet WJ, Meyer zum Büschenfelde K-H (1994) Drug-induced hepatitis: a rare complication of oral anticoagulants. J Hepatol 21:447–449

    Article  PubMed  CAS  Google Scholar 

  • Hoof F van, Hageman-Bal M (1967) Progressive familial myoclonic epilepsy with Lafora bodies — electronmicroscopic and histochemical study of a cerebral biopsy. Acta Neuropathol 7:315–326

    Article  PubMed  Google Scholar 

  • Horn T, Junge J, Christoffersen P (1986) Early alcoholic liver injury: activation of lipocytes in acinar zone 3 and correlation to the degrees of collagen formation in the Disse space. J Hepatol 3:333–340

    Article  PubMed  CAS  Google Scholar 

  • Horst DA, Grace ND, LeComple PM (1980) Prolonged cholestasis and progressive hepatic fibrosis following imipramime therapy. Gastroenterology 79:550–554

    PubMed  CAS  Google Scholar 

  • Hruban Z, Slesers A, Hopkins E (1972) Drug-induced and naturally occuring myelin bodies. Lab Invest 27:62–70

    PubMed  CAS  Google Scholar 

  • Huchzermeyer H, Münzenmaier R (1995) Lovastatin-induzierte akute cholestatische Hepatitis. Dtsch Med Wochenschr 120:252–256

    Article  PubMed  CAS  Google Scholar 

  • Iseri OA, Gottlieb LS (1971) Alcoholic hyalin and megamitochondria as separate and distinct entities in liver disease associated with alcoholism. Gastroenterology 60:1027–1035

    PubMed  CAS  Google Scholar 

  • Ishak KG (1979) Hepatic neoplasmas associated with contraceptive and anabolic steroids. In: Lingeman CH (ed) Carcinogenic hormones. Springer, Berlin Heidelberg New York, pp 73–128

    Google Scholar 

  • Ishak KG (1981) Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis 1:116–128

    Article  PubMed  CAS  Google Scholar 

  • Ishak KG, Irey NS (1972) Hepatic injury associated withe the phenothiazines. Clinico-pathologic and follow-up study of 36 patients. Arch Pathol 93:283–304

    PubMed  CAS  Google Scholar 

  • Ishak KG, Zimmerman HJ (1988) Drug-induced and toxic granulomatous hepatitis. Baillieres Clin Gastroenterol 2:463–480

    Article  PubMed  CAS  Google Scholar 

  • Jezequel AM (1976) Ultrastructural changes induced by drugs. In: Taylor W (ed) The hepatobiliary system. Fundamental and pathological mechanism. Plenum Press, New York London, pp 179–200

    Google Scholar 

  • Jones JK, Carr SW van de, Zimmerman H, Leroy A (1983) Heptotoxicity associated with phenothiazines. Psychopharmacol Bull 19:24–27

    PubMed  CAS  Google Scholar 

  • Kalantzis N, Gabriel P, Mouzas J, Tiniakos D, Tsigas D, Tiniakos G (1991) Acute amiodaroneinduced hepatitis. Hepatogastrotenterology. 38:71–74

    CAS  Google Scholar 

  • Kamm MA, Davies DJ, Breen KJ (1988) Acute hepatitis due to etretinate. J Gastroenterol Hepatol 3:633–666

    Article  Google Scholar 

  • Kane JA, Kane SP, Jain S (1995) Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36:146–147

    Article  PubMed  CAS  Google Scholar 

  • Kaneda K, Dan C, Wake K (1986) “Giant vacuoles” formed in Kupffer cells after the latex particle injection. Inn: Kirn A, Knook DL, Wisse E (eds) Cells of the hepatic sinusoid, vol 1. Proceedings of the Third International Kupffer Cell Symposium held in Strasbourg, France, 23-27 September, 1985. The Kupffer Cell Foundation, Rijswijk, pp 163–164

    Google Scholar 

  • Keiding S (1995) Drug administration to liver patients: aspects of liver pathophysiology. Semin Liver Dis 15:268–282

    Article  PubMed  CAS  Google Scholar 

  • Kenna JG, Neuberger J, Williams R (1988) Evidence for expression in human liver of halothaneinduced neoantigens recognized by antibodies in sera from patients with halothane hepatitis. Hepatology 8:1635–1641

    Article  PubMed  CAS  Google Scholar 

  • Kenna JG, Pelt FNAM van (1994) The metabolism and toxicity of inhaled anaesthetic agents. Anaesth Pharmacol Rev 2:29–42

    CAS  Google Scholar 

  • Khedun SM, Maharaj B, Leary WP (1992) The effects of supra-therapeutic doses of rifampicin on liver function in the perfused rat liver. Int J Exp Pathol 73:449–453

    PubMed  CAS  Google Scholar 

  • Kiessling K-H, Pilstr6m L (1971) Ethanol and the human liver. Structural and metabolic changes in liver mitochondria. Cytobiologie 4:339–348

    Google Scholar 

  • King PD, Blitzer BL (1990) Drug-induced cholestasis: pathogenesis and clinical features. Semin Liver Dis 10:316–338

    Article  PubMed  CAS  Google Scholar 

  • Klatskin G (1977) Hepatic tumours: possible relationship to use of oral contraceptives. Gastroenterology 73:386–394

    PubMed  CAS  Google Scholar 

  • Klauw MM van der, Houtman PM, Stricker BHC, Spoelstra P (1994) Hepatic injury caused by benzbromarone. J Hepatol 20:376–379

    PubMed  Google Scholar 

  • Klein S, Nealon WH (1988) Hepatobiliary abnormalities associated with total parenteral nutrition. Semin Liver Dis 8:237–246

    Article  PubMed  CAS  Google Scholar 

  • Klinge O (1973a) Kernveränderungen und Kernteilungsstörungen in der Altersleber. Gerontologica 19:314–339

    Article  CAS  Google Scholar 

  • Klinge O (1973b) Cytologic and histologic aspects of toxically induced liver reactions. Curr Top Pathol 58:91–116

    PubMed  CAS  Google Scholar 

  • Klinge O (1974) Chronische toxische Hepatosen und ihre morphologischen Beziehungen zur chronischen Hepatitis. In: Wannagat L (Hrsg) Chronische Hepatitis — Zirrhosen. Thieme, Stuttgart, S 31–41

    Google Scholar 

  • Klinge O (1976) Agranulares endoplasmatisches Retikulum — die strukturelle Grundlage der Biotransformation in der Leber. In: Wannagat L (Hrsg) Toxische Leberschäden. Thieme, Stuttgart, S 21–33

    Google Scholar 

  • Klinge O (1995) Intrahepatische Cholangitis auf vermutlich immunologischer Grundlage. Verh Dtsch Ges Pathol 79:198–232

    PubMed  CAS  Google Scholar 

  • Klinge O, Altmann H-W (1971) Morphologie toxischer Hepatosen. Münch Med Wochenschr 113:1529–1539

    PubMed  CAS  Google Scholar 

  • Klinge O, Altmann H-W (1973) Punktathistologie drogenbedingter Leberreaktionen. In: Kühn HA, Markoff NG, Meier MS (Hrsg) Aktuelle Hepatologie. Thieme, Stuttgart, S 8–22

    Google Scholar 

  • Klinge O, Pfeifer U (1979) Pigmentablagerungen in der Leber. In: Kühn HA, Wernze H (Hrsg) Klinische Hepatologie. Thieme, Stuttgart, S 1.43–1.52

    Google Scholar 

  • Klinge O, Ross W, Struder E (1975) Das Karyogramm normaler und verfetteter Lebern des Menschen. Virchows Arch A 366:203–222

    CAS  Google Scholar 

  • Knolle J, Förster E, Roessner A, Themann H, Hohn P, Meyer zum Büschenfelde K-H (1974) Die nicht-zirrhotische portale Fibrose (hepatoportale Sklerose) nach chronischer Arsenvergiftung. Dtsch Med Wochenschr 99:903–908

    Article  PubMed  CAS  Google Scholar 

  • Knowles II BM, Wolff MW (1976) Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol 7:533–545

    Article  PubMed  CAS  Google Scholar 

  • Koelma IA, Nap M, Hitema S, Krom RAF, Houthoff HJ (1986) Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 110:1035–1040

    PubMed  CAS  Google Scholar 

  • Kohn N, Myerson RM (1961) Xanthomatous biliary cirrhosis following chlorpromazine. Am J Med 31:665–670

    Article  PubMed  CAS  Google Scholar 

  • Kowalski TE, Falestini M, Furth E, Malet PF (1994) Vitamin A hepatotoxicitiy: a cautionary note regarding 25,000 IU supplements. Am J Med 97:523–528

    Article  PubMed  CAS  Google Scholar 

  • Küpfer A, Preisig R (1983) Inherited defects of hepatic drug metabolism. Semin Liver Dis 3:341–354

    Article  PubMed  Google Scholar 

  • Kunelis CT, Peters JL, Edmondson HA (1965) Fatty liver of pregnancy and its relationship to Tetracycline therapy. Am J Med 38:359–377

    Article  PubMed  CAS  Google Scholar 

  • Landas SK, Mitros FA, Furst DE, LaBreque DR (1992) Lipogranulomas and gold in the liver in rheumatoid arthritis. Am J Surg Pathol 16:171–174

    Article  PubMed  CAS  Google Scholar 

  • Larrey D, Pageaux GP (1995) Hepatotoxicity of herbal remedies and mushrooms. Semin Liver Dis 15:183–188

    Article  PubMed  CAS  Google Scholar 

  • Laskin DL (1990) Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 10:293–304

    Article  PubMed  CAS  Google Scholar 

  • Lepper MH, Wolfe CK, Zimmerman HJ, Caldwell ER, Spies HW, Dowling HF (1953) Effects of large doses of aureomycin on human liver. Arch Intern Med 88:271–283

    Google Scholar 

  • Levy M, Goodman MW, van Dyke BJ, Summer HW (1981) Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 95:64–65

    PubMed  CAS  Google Scholar 

  • Lewin K, Millis RR (1973) Human radiation hepatitis. A morphologic study with emphasis on the late stages. Arch Pathol 96:21–26

    PubMed  CAS  Google Scholar 

  • Lewis JH, Zimmerman HJ, Benson GD, Ishak KG (1984) Hepatic injury associated with Katoconazol therapy. Analysis of 33 cases. Gastroenterology 86:503–513

    PubMed  CAS  Google Scholar 

  • Lewis JH, Mullick FG, Ishak KG, Ranard RC, Ragsdale B, Perse RM et al. (1990) Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 21:59–67

    Article  PubMed  CAS  Google Scholar 

  • Lewis O, Wainwright HC, KEW HC; Zwi S, Isaacson C (1979) Liver damage associated with perhexiline maleate. Gut 20:186–189

    Article  PubMed  CAS  Google Scholar 

  • Lindner H, Weber D, Kloppel G (1976) Prajmaliumbitartrat-induzierte Leberschaden. Dtsch Med Wochenschr 101:1876–1880

    Article  PubMed  CAS  Google Scholar 

  • Linthoudt D van, Buss W, Beyner F, Ott H (1991) Nécrose hépatique fatale au cours d’un traitement aux sels d’or d’une polyarthrite rhumatoide. Schweiz Med Wochenschr 121:1099–1102

    PubMed  Google Scholar 

  • Loomus GN, Aneja P, Bota RA (1983) A case of peliosis hepatis in association with tamoxifentherapy. Am J Clin Pathol 80:881–883

    PubMed  CAS  Google Scholar 

  • Luca LM de, Creek KE (1986) Vitamin A and the liver. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol VIII. Grune & Stratton, Orlando, pp 81–98

    Google Scholar 

  • Ludwig J, Axelsen R (1983) Drug effects on the liver. An updated compilation of drugs and drugrelated hepatic diseases. Dig Dis Sci 28:651–666

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Viggiano TR, McGill DB, Ott BJ (1980) Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hiterto unnamed disease. Mayo Clin Proc 55:434–438

    PubMed  CAS  Google Scholar 

  • Ludwig J, Kim CH, Wiesner RH, Krom RA (1989) Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 9:215–218

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Hashimoto E, Obata H, Baldus WP (1993) Idiopathic portal hypertension: a histopathological study of 26 Japanese cases. Histopathology 22:227–234

    Article  PubMed  CAS  Google Scholar 

  • Lüders CJ, Riske WEO, Henning H, Vogel H-M (1975) Die Histomorphologie der Leber bei Schadigung mit phenolisatinhaltigen Laxantien (rezidivierende chronische Cholangiohepatitis). Virchows Arch A 365:309–325

    Google Scholar 

  • Lüllmann H, Lüllmann-Rauch R, Wasserman O (1975) Drug induced phospholipidosis. Crit Rev Toxicol 4:185–218

    Google Scholar 

  • Lukomska B, Pienkowska B, Andrzejewski W, Olszewski WL (1991) Liver sinusoidal cytotoxic cells are recruited from blood and divide locally. J Hepatol 12:332–335

    Article  PubMed  CAS  Google Scholar 

  • Maddrey WC, Boitnott JK (1975) Severe hepatitis from methyldopa. Gastroenterology 68:351–360

    Google Scholar 

  • Maddrey WC, Boitnott JK (1979) Drug-induced chronic hepatitis and cirrhosis. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol VI. Grune & Stratton, New York, pp 595–603

    Google Scholar 

  • Mallat A, Dhumeaux D (1991) Cocaine and the liver. J Hepatol 12:275–278

    Article  PubMed  CAS  Google Scholar 

  • Marzabadi MR, Sohal RS, Brunk UT (1991) Mechanisms of lipofuscinogenesis: effect of the inhibition of lysosomal proteinases and lipases under varying concentrations of ambient oxygen in cultured rat neonatal myocardial cells. APMIS 99:416–426

    Article  PubMed  CAS  Google Scholar 

  • Mason A, Sallie R (1995) What causes fulminant hepatic failure of unknown etiology? Am J Clin Pathol 104:491–494

    PubMed  CAS  Google Scholar 

  • Mathew J, Hines JE, James OFW, Burt AD (1994) Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. J Hepatol 20:537–541

    Article  PubMed  CAS  Google Scholar 

  • Matsumoto T, Yoshimine T, Shimouchi K, Shiotu H, Kuwabara N, Fukuda Y, Hoshi T (1992) The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese autopsy registry date. Hum Pathol 23:1151–1158

    Article  PubMed  CAS  Google Scholar 

  • Mays ET, Christopherson W (1984) Hepatic tumors induced by sex steroids. Semin Liver Dis 4:147–157

    Article  PubMed  CAS  Google Scholar 

  • McCaughan GW, Bilous MJ, Gallagher ND (1985) Long-term survival with tumor regression in androgen-induced liver tumors. Cancer 56:2622–2626

    Article  PubMed  CAS  Google Scholar 

  • McDonald GB, Tirumali N (1984) Intestinal and liver toxicity of neoplastic drugs. West J Med 140:250–259

    PubMed  CAS  Google Scholar 

  • McMaster KR, Hennigar GR (1981) Drug-induced granulomatous hepatitis. Lab Invest 44: 61–73

    PubMed  Google Scholar 

  • Meijer DKF, Molema G (1995) Targeting of drugs to the liver. Semin Liver Dis 15:202–256

    Article  PubMed  CAS  Google Scholar 

  • Meyer UA, Zanger UM, Skoda RC, Grant D, Blum M (1990) Genetic polymorphism of drug metabolism. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol IX. Grune & Stratton, New York, pp 307–323

    Google Scholar 

  • Meyler’s side effects of drugs (1996/1997), vol 13. Elsevier, Amsterdam New York Oxford

    Google Scholar 

  • Miller EC, Miller JA (1976) Hepatocarcinogenesis by chemicals. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol V. Grune & Stratton, New York, pp 699–711

    Google Scholar 

  • Mölleken K (1979) Liver biopsy findings after intake of oral contraceptives. Zentralbl Allg Pathol 123:195–201

    PubMed  Google Scholar 

  • Morris JS, Schmid M, Newman S, Scheuer PJ, Sherlock S (1974) Arsenic and non cirrhotic portal hypertension. Gastroenterology 66:86–94

    PubMed  CAS  Google Scholar 

  • Moss RL, DAS JB, Raffensperger JG (1993) Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg 28:1270–1275

    Article  PubMed  CAS  Google Scholar 

  • Myers MG (1982) Hepatic cellular injury during varicella. Arch Dis Child 57:317–319

    Article  PubMed  CAS  Google Scholar 

  • Myers JL, Augur Jr NA (1984) Hydralazine-induced cholangitis. Gastroenterology 87:1185–1188

    PubMed  CAS  Google Scholar 

  • Nadell J, Kosek J (1977) Peliosis hepatis. Twelve cases associated with oral androgen therapy.Arch Pathol Lab Med 101:405–410

    PubMed  CAS  Google Scholar 

  • Nakamura H, Uehara H, Okada T, Kambe H, Kimura Y, Ito H et al. (1989) Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody. Hepatogastroenterology 36:393–397

    PubMed  CAS  Google Scholar 

  • Nakashima O, Sugihara S, Eguchi A, Taguchi J, Watanabe J, Kojiro M (1992) Pathomorphologic study of pale bodies in hepatocellular carcinoma. Acta Pathol Jpn 42:414–418

    PubMed  CAS  Google Scholar 

  • Nebert DW, McKinnon RA (1994) Cytochrome P450: evolution and functional diversity. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol XII. WB Saunders, Philadelphia, pp 63–97

    Google Scholar 

  • Nelson SD (1990) Molecular mechanism of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 10:267–278

    Article  PubMed  CAS  Google Scholar 

  • Neuberger J, Kenna JG, Aria KN, Williams R (1985) Antibody mediated hepatocyte injury in methyldopa-induced hepatotoxicity. Gut 26:1233–1239

    Article  PubMed  CAS  Google Scholar 

  • Nohlgard C, Rubio CA, Kock Y, Hammar H (1993) Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis. J Am Acad Dermatol 28:40–45

    Article  PubMed  CAS  Google Scholar 

  • Oldershausen H-F von (1968) Schwangerschaftsikterus und ovulationshemmende Steroide. Dtsch Med J 19:394–403

    Google Scholar 

  • Olsson R, Wiholm B-E, Sand C, Zettergren L, Hultcrantz R, Myrhed M (1992) Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J Hepatol 15:154–161

    Article  PubMed  CAS  Google Scholar 

  • Ortega L, Landa Garcia JI, Torres Garcia A, Silecchia G, Arenas J, Suarez A et al. (1985) Acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 5:673–676

    Article  PubMed  CAS  Google Scholar 

  • Osterloh J, Cunningham W, Dixon A, Combest D (1989) Biochemical relationships between Reye’s and Reye’s-like metabolic and toxicological syndromes. Med Toxicol Adverse Drug Exp 4:272–294

    PubMed  CAS  Google Scholar 

  • Partin JC, Schubert WK, Partin JS (1971) Mitochondrial ultrastructure in Reye’s syndrome (encephalopathy and fatty degeneration of the viscera). N Engl J Med 285:1339–1349

    Article  PubMed  CAS  Google Scholar 

  • Partin JS, Daugherty CC, McAdams AJ, Partin JC, Schubert WK (1984) A comparison of liver ultrastructure in salicylate intoxication and Reye’s syndrome. Hepatology 4:687–690

    Article  PubMed  CAS  Google Scholar 

  • Passo B, Harrison DC (1975) A new look at an old problem: mushroom poisoning. Am J Med 58:505–509

    Article  Google Scholar 

  • Paulini K, Beneke G, Kulka R (1971) Der Mechanismus der Lebervergrofierung nach verschieden hoher Phenobarbitaldosis. Beitr Pathol 143:283–294

    PubMed  CAS  Google Scholar 

  • Pelt FNAM van, Straub P, Manns MP (1995) Molecular basis of drug-induced immunological liver injury. Semin Liver Dis 15:283–300

    Article  PubMed  Google Scholar 

  • Perez V, Schaffner F, Popper H (1972) Hepatic drug reaction. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol 4. Grune & Stratton, New York, pp 597–625

    Google Scholar 

  • Perharic-Walton L, Murray V (1992) Toxicity of Chinese herbal remedies. Lancet 340:674

    Article  PubMed  CAS  Google Scholar 

  • Pessayre D (1992) Drug-induced liver disease. In: Prieto J, Rodes J, Shafritz DA (eds) Hepatobiliary diseases. Spinger, Berlin Heidelberg New York Tokyo, pp 697–727

    Google Scholar 

  • Pessayre D (1995) Role of reactive metabolites in drug-induced hepatitis. J Hepatol 23 (Suppl 1):16–24

    PubMed  CAS  Google Scholar 

  • Pessayre D, Bichara M, Feldmann G, Degott C, Patet F, Benhamou JP (1979) Perhexiline maleateinduced cirrhosis. Gastroenterology 76:170–177

    PubMed  CAS  Google Scholar 

  • Pessayre D, Larrey D (1988) Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol 2:385–422

    Article  PubMed  CAS  Google Scholar 

  • Peters RL (1977) Patterns of hepatic morphology in jejunoileal bypass patients. Am J Clin Nutr 30:53–57

    PubMed  CAS  Google Scholar 

  • Peters RL, Edmondson HA, Mikkelsen W, Tatter D (1967) Tetracycline induced fatty liver in non-pregnant patients. Am J Surg 113:622–632

    Article  PubMed  CAS  Google Scholar 

  • Pfeifer U (1976) Lysosomen und Autophagic Verh Dtsch Ges Pathol 60:28–64

    Google Scholar 

  • Phillips MJ, Oda M, Funatsu K (1978) Evidence of microfilament involvement in norethendrolone-induced intrahepatic cholestasis. Am J Pathol 93:729–744

    PubMed  CAS  Google Scholar 

  • Pimentel JC, Menezes AP (1977) Liver disease in vineyard sprayers. Gastroenterology 71:275–283

    Google Scholar 

  • Pohl LR (1990) Drug-induced allergic hepatitis. Semin Liver Dis 10:305–315

    Article  PubMed  CAS  Google Scholar 

  • Pohl LR, Kenna JG, Satoh H, Christ D, Martin JL (1989) Neoantigens associated with halothane hepatitis. Drug Metab Rev 20:203–217

    Article  PubMed  CAS  Google Scholar 

  • Popper H, Rubin E, Gardiol D, Schaffner F, Paronetto F (1965) Drug-induced liver disease: penalty for progress. Arch Intern Med 115:125–136

    Google Scholar 

  • Poucell S, Ireton J, Valencia-Mayoral P, Downar E, Larratt L, Patterson J et al. (1984) Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. Gastroenterology 86:926–936

    PubMed  CAS  Google Scholar 

  • Poupon R, Rosensztajn L, Prudhomme de Saint-Maur P, Lageron A, Gombeau T, Darnis F (1980) Perhexiline maleate-associated hepatic injury prevalence and characteristics. Digestion 20:145–150

    Article  PubMed  CAS  Google Scholar 

  • Powell CJ, Charles SJ, Mullervy J (1994) Cocaine hepatotoxicity: a study on the pathogenesis of periportal necrosis. Int J Exp Pathol 75:415–424

    PubMed  CAS  Google Scholar 

  • Price Evans DAP, Manley KA, McKusick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2:485–491

    Article  PubMed  CAS  Google Scholar 

  • Quigley EMM, Zetterman RK (1988) Hepatobiliary complications of malabsorption and malnutrition. Semin Liver Dis 8:218–228

    Article  PubMed  CAS  Google Scholar 

  • Rao MS, Subbaro V, Yeldandi AV, Reddy JK (1992) Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 52:2977–2979

    PubMed  CAS  Google Scholar 

  • Redlich CA, West AB, Fleming L, True LD, Cullen MR, Riely CA (1990) Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide. Gastroenterology 99:748–757

    PubMed  CAS  Google Scholar 

  • Reed GB jr, Cox AJ jr (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597–611

    PubMed  Google Scholar 

  • Reichen J (1995) Assessment of hepatic function with xenobiotics. Semin Liver Dis 15:189–201

    Article  PubMed  CAS  Google Scholar 

  • Reinl W, Urban HJ (1965) Erkrankungen durch Dimethylformamid. Int Arch Gewerbepathol Gewerbehyg 21:333–346

    Article  CAS  Google Scholar 

  • Remington PL, Rowley D, McGee H, Hall WN, Monto AS (1986) Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 77:93–98

    PubMed  CAS  Google Scholar 

  • Remmer H (1969) Die Entgiftungsfunktion der Leber. In: Kühn HA, Liehr H (Hrsg) Aktuelle Hepatologie. Thieme, Stuttgart, S 98–108

    Google Scholar 

  • Remmer H, Merker H-J (1963) Enzyminduktion und Vermehrung von endoplasmatischem Retikulum in der Leberzelle wahrend der Behandlung mit Phenobarbital (Luminal). Klin Wochenschr 41:276–283

    Article  PubMed  CAS  Google Scholar 

  • Reynolds TB (1975) Laxative liver disease. In: Gerok W, Sickinger K (eds) Drugs and the liver. Schattauer, Stuttgart New York, pp 319–325

    Google Scholar 

  • Riely CA (1988) Case studies in jaundice of pregnancy. Semin Liver Dis 8:191–199

    Article  PubMed  CAS  Google Scholar 

  • Rio B, Cahn JY, Attal M, Drouet L, Scrobohaci ML, Degos F et al. (1994) Hepatic venoocclusive disease following bone marrow transplantation. Proceedings of a symposium of FAG and GEGMO groups. Presse Med 23:1217–1222

    PubMed  CAS  Google Scholar 

  • Rössle R (1929) Hepatose und Hepatitis. Schweiz Med Wochenschr 59:4–9

    Google Scholar 

  • Rolfes DB, Ishak KG (1985) Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 5:1149–1157

    Article  PubMed  CAS  Google Scholar 

  • Rolfes DB, Ishak KG (1986) Liver disease in pregnancy. Histopathology 10:555–570

    Article  PubMed  CAS  Google Scholar 

  • Roschlau G (1983) Hepatitis mit konfluierenden Nekrosen durch Dihydralazin (Depressan). Eine klinisch-pathologische Studie an Hand von 20 Fallen. Zentralbl Allg Pathol 127:385–393

    PubMed  CAS  Google Scholar 

  • Roth F (1956) Über die chronische Arsenvergiftung der Moselwinzer unter besonderer Berücksichtigung des Arsenkrebses. Z Krebsforsch 61:287–319

    Article  PubMed  CAS  Google Scholar 

  • Roth F (1957) Arsen-Leber-Tumoren (Haemangioendotheliom) Z Krebsforsch 62:468–503

    Google Scholar 

  • Ruben FL (1991) Reye syndrome. In: Belshe RB (ed) Textbook of human virology, 2nd edn. Mosby Year Book, St. Louis, pp 1033–1043

    Google Scholar 

  • Rubin E, Beattie DS, Lieber CS (1970) Effect of ethanol on the biogenesis of mitochondrial membranes and associated mitochondrial functions. Lab Invest 23:620–627

    PubMed  CAS  Google Scholar 

  • Rubin E, Florman AL, Degnan T, Diaz J (1970) Hepatic injury in chronic hypervitaminosis A. Am J Dis Child 119:132–138

    PubMed  CAS  Google Scholar 

  • Ruebner BH, Montgomery CK, French SW (1991) Diagnostic pathology of the liver and biliary tract: Fatty liver. Hemisphere, New York, pp 141–154

    Google Scholar 

  • Saez-Royuela F, Lopez-Vasquez A, Lopez-Moranta A (1995) Pentoxifylline-induced acute hepatitis. J Hepatol 23:482–483

    Article  PubMed  CAS  Google Scholar 

  • Saibara T, Himeno H, Ueda H, Onishi S, Yamamoto Y, Enzan H et al. (1994) Acute hepatic failure with swollen mitochondria and microvesicular fatty degeneration of hepatocytes triggered by free radical initiator. Lab Invest 70:517–524

    PubMed  CAS  Google Scholar 

  • Salete Trigueiro de Araujo M, Gerard F, Chossegros P, Christovao Porto L, Barlet P, Grimaud J-A (1990) Vascular hepatotoxicity related to heroin addiction. Virchows Arch A 417:497–503

    Article  Google Scholar 

  • Salete Trigueiro de Araujo M, Gerard F, Chossegros P, Guerret S, Grimaud J-A (1992) Lack of hepatocyte involvement in the genesis of the sinusoidal dilatation related to heroin addiction: a morphometric study. Virchows Arch A 420:149–153

    Article  Google Scholar 

  • Samuels AM, Carey MC (1978) Effects of chlorpromazine hydrochloride and its metabolites on Mg2+-and Na+, K+-ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenterology 74:1183–1190

    PubMed  CAS  Google Scholar 

  • Sanchez-Lanier M, Davis LE, Blisard KS, Woodfin BM, Wallace JM, Caskey LS (1991) Influenza A virus in the mouse: hepatic and cerebral lesions in a ReyeVsyndrome-like illnes. Int J Exp Pathol 72:489–500

    PubMed  CAS  Google Scholar 

  • Sarachek NS, London RL, Matulewicz TC (1985) Diltiazem and granulomatous hepatitis. Gastroenterology 88:1260–1262

    PubMed  CAS  Google Scholar 

  • Schaffner F, Thaler H (1986) Nonalcoholic fatty liver disease. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol VIII. Grune & Stratton, New York, pp 283–298

    Google Scholar 

  • Schapira D, Bassan L, Nahir AM, Scharf Y (1986) Diclofenac-induced hepatotoxicity. Postgrad Med J 62:63–65

    Article  PubMed  CAS  Google Scholar 

  • Schenker B, Breen KJ, Heimberg M (1976) Pathogenesis of tetracycline-induced fatty liver. In: Gerok W, Sickinger K (eds) Drugs and the liver. Schattauer, Stuttgart New York, pp 269–280

    Google Scholar 

  • Scheuer PJ (1980) Liver biopsy interpretation 3rd edn. Williams & Wilkins, Baltimore, pp 88–101

    Google Scholar 

  • Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM (1992) The pathology of hepatitis C. Hepatology 15:567–571

    Article  PubMed  CAS  Google Scholar 

  • Schochel SS jr, McCormick WF, Zellweger H (1970) Type IV glycogenosis (amylopectinosis). Light and electron microscopic observations. Arch Pathol 90:354–363

    Google Scholar 

  • Schulte-Hermann R (1973) Induction of liver growth by xenobiotic compounds and other stimuli. Crit Rev Toxicol 3:97–158

    Article  Google Scholar 

  • Schumacher K (1970) Immunpathologische Phanomene bei chronischer Hepatitis. Internist 11:11–17

    PubMed  CAS  Google Scholar 

  • Seeff LB (1981) Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Semin Liver Dis 1:104–115

    Article  PubMed  CAS  Google Scholar 

  • Seidegard J, Vorachek WR, Pero RW, Pearson RW (1988) Hereditary differences in the expression of human glutathion transferase activity on transstilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85:7293–7297

    Article  PubMed  CAS  Google Scholar 

  • Seifert WF, Roholl PJM, Blauw B, Ham F van der, Thiel van, Ruiter CF de, Seifert-Bock I et al. (1994) Fat-storing cells and myofibroblasts are involved in the initial phase of carbon tetrachloride-induced hepatic fibrosis in BN/BiRij rats. Int J Exp Pathol 75:131–146

    PubMed  CAS  Google Scholar 

  • Sharp JR, Ishak KG, Zimmerman HJ (1980) Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 92:14–19

    PubMed  CAS  Google Scholar 

  • Shaw GR, Anderson WR (1991) Multisystem failure and hepatic microvesicular fatty metamorphosis associated with Tolmetin ingestion. Arch Pathol Lab Med 115:818–821

    PubMed  CAS  Google Scholar 

  • Shear NH, Spielberg SP (1988) Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 82:1826–1832

    Article  PubMed  CAS  Google Scholar 

  • Shibayama Y, Asaka S, Nakata K (1993) Augmentation of endotoxin hepatotoxicity by zinc. Exp Toxicol Pathol 45:351–354

    PubMed  CAS  Google Scholar 

  • Side effects of drugs annual (1977-1994) Dukes MNG (ed): vol 1-15, Aronson JK, Boxtel CJ van (eds) vol 16-18

    Google Scholar 

  • Silva MO, Roth D, Reddy R, Fernandez JA, Albores-Saavedra J, Schiff ER (1991) Hepatic dysfunction accompanying acute cocaine intoxication. J Hepatol 12:312–315

    Article  PubMed  CAS  Google Scholar 

  • Silverman JA, Thorgeirsson SS (1995) Regulation and function of the multidrug resistance genes in the liver. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol XIII. Saunders, Philadelphia, pp 101–123

    Google Scholar 

  • Simon JB, Manley PN, Brien JF, Armstrong PW (1984) Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 311:167–172

    Article  PubMed  CAS  Google Scholar 

  • Smetana HF (1963) The histopathology of drug-induced liver disease. Ann NY Acad Sci 104:821–846

    CAS  Google Scholar 

  • Sotaniemi EA, Sutinen S, Sutinen S, Arranto AJ, Pelkonen RO (1982) Liver injury in subjects occupationally exposed to chemicals. Acta Med Scand 212:207–215

    Article  PubMed  CAS  Google Scholar 

  • Speck RF, Schranz C, Lauterburg BH (1993) Prednisolone stimulates glutathione synthesis in mice. Protection by prednisolone against acetaminophen hepatotoxicity in vivo. J Hepatol 18:62–67

    Article  PubMed  CAS  Google Scholar 

  • Spreckelsen U, Kirchhoff R, Haacke H (1991) Cholestatischer Ikterus während Lovastatin-Einnahme. Dtsch Med Wochenschr 116:739–740

    Article  PubMed  CAS  Google Scholar 

  • Stenger RJ (1970) Organelle pathology of the liver. The endoplasmic reticulum. Gastroenterology 58:554–574

    PubMed  CAS  Google Scholar 

  • Stenwig AE, Solgaard T (1975) Ruptured benign hepatoma associated with an oral contraceptive. A case report. Virchows Arch A 367:337–343

    CAS  Google Scholar 

  • Stricker BHC (1992) Drug-induced hepatic injury, 2nd edn. Elsevier, Amsterdam

    Google Scholar 

  • Stricker BHC, Spoelstra P (1985) Drug induced hepatic injury. Elsevier, Amsterdam

    Google Scholar 

  • Stromeyer FW, Ishak KG, Gerber MA, Mathew T (1980) Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 74:254–258

    PubMed  CAS  Google Scholar 

  • Swank LA, Chajfer G, Namchansky BA (1978) Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Arch Intern Med 138:997–998

    Article  PubMed  CAS  Google Scholar 

  • Stuart KL, Bras G (1957) Veno-occlusive disease of the liver. Q J Med 26:291–315

    PubMed  CAS  Google Scholar 

  • Tabuenca JM (1981) Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with Anilin. Lancet II: 567–568

    Article  Google Scholar 

  • Tao LC (1991) Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma: cytomorphology and mechanism of malignant transformation. Cancer 68:341–347

    Article  PubMed  CAS  Google Scholar 

  • Terada T, Nakanuma Y (1995) Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas. Histopathology 27:333–339

    Article  PubMed  CAS  Google Scholar 

  • Tesluk H, Lawrie J (1981) Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol 105:296–299

    CAS  Google Scholar 

  • Thompson O, Reinicke V (1981) Grund glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan). Liver 1:67–73

    Google Scholar 

  • Toft E, Vyberg M, Therkelsen K (1991) Diltiazem-induced granulomatous hepatitis. Histopathology 18:474–475

    Article  PubMed  CAS  Google Scholar 

  • Touraine RL, Bertrand Y, Foray P, Gilly J, Philippe N (1993) Hepatic tumours during androgen therapy in Fanconi’s anaemia. Eur J Pediatr 152:691–693

    Article  PubMed  CAS  Google Scholar 

  • Tran A, Housset C, Boboc B, Tourani J-M, Carnot F, Berthelot P (1991) Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments. J Hepatol 12:36–39

    Article  PubMed  CAS  Google Scholar 

  • Trigueiro de Araujo MS, Gerard F, Chossegros P, Guerret S, Barlet P, Adeleine P, Grimaud J-A (1993) Cellular and matrix changes in drug abuser liver sinusoids: a semiquantitative and morphometric ultrastructural study. Virchows Arch A 422:145–152

    Article  Google Scholar 

  • Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D et al. (1985) Primary myeoloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 103:329–334

    PubMed  CAS  Google Scholar 

  • Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou J-P (1986) Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 90:807–811

    PubMed  CAS  Google Scholar 

  • Varner M, Rinderknecht NK (1980) Acute fatty metamorphosis of the liver in pregnancy. A maternal mortality and literature review. J Reprod Med 24:177–180

    PubMed  CAS  Google Scholar 

  • Vazquez JJ, Pardo-Mindan J (1979) Liver cell injury (bodies similar to Lafora’s) in alcoholics treated with disulfiram (Antabuse). Histopathology 3:377–384

    Article  PubMed  CAS  Google Scholar 

  • Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston ALWF, Davies M, Williams R (1980) Antibodies to the surface of halo thane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303:66–71

    Article  PubMed  CAS  Google Scholar 

  • Vessey DA (1990) Metabolism of drugs and toxins by human liver. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of liver disease, vol 1, 2nd edn. Saunders, Philadelphia, pp 196–234

    Google Scholar 

  • Vierling JM (1990a) Hepatobiliary complications of ulcerative colitis and Crohn’s disease. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of liver disease, 2nd edn. Saunders, Philadelphia, pp 1126–1158

    Google Scholar 

  • Vierling JM (1990b) Primary biliary cirrhosis. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of liver disease, 2nd edn. Saunders, Philadelphia, pp 1158–1205

    Google Scholar 

  • Villari D, Rubino F, Corica F, Spinella S, Cesare E di, Longo G, Raimondo G (1995) Bile duct ductopenia following therapy with sulpiride. Virchows Arch 427:223–226

    Article  PubMed  CAS  Google Scholar 

  • Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797

    Article  PubMed  CAS  Google Scholar 

  • Wanless IR, Geddie WR (1985) Mineral oil lipogranulomata in liver and spleen. A study of 465 autopsies. Arch Pathol Lab Med 109:283–286

    PubMed  CAS  Google Scholar 

  • Wanless IR, Dore S, Gopinath N, Tan J, Cameron R, Heathcote EJ et al. (1990) Histopathology of cocaine hepatotoxicity. Report of four patients. Gastroenterology 98:497–501

    PubMed  CAS  Google Scholar 

  • Watkins PB (1990) Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin Liver Dis 10:235–250

    Article  PubMed  CAS  Google Scholar 

  • Weber TR, Gross KR, Grosfeld JL (1983) Intrahepatic cholestasis and endotoxemia: implications for liver disease related to total parenteral nutrition. In: Kasai M (ed) Biliary atresia and its related disorders. Proceedings of an Internation Symposium, Sendai, Japan. Excerpta Medica, Amsterdam, pp 31–37

    Google Scholar 

  • Weber WW (1987) The acetylator genes and drug response. Oxford University Press, New York

    Google Scholar 

  • Wepler W (1971) Morphologie chronischer Leberkrankheiten. Leber Magen Darm 1:45–50

    Google Scholar 

  • Westphal SA (1994) Hepatotoxicity from propylthiouracil. South Med J 87:943–947

    Article  PubMed  CAS  Google Scholar 

  • Westphal T (1972) Struktur und Wirkung der Amatoxine. Naturwissenschaften 59:225–231

    Article  Google Scholar 

  • Williams AT, Burk RF (1990) Carbon tetrachloride hepatotoxicity: an example of free radicalmediated injury. Semin Liver Dis 10:279–284

    Article  PubMed  CAS  Google Scholar 

  • Williamson J, Chopin J (1980) Adverse reactions to prescribed drugs in the elderly: a multicenter investigation. Age Ageing 9:73–80

    Article  PubMed  CAS  Google Scholar 

  • Woolley S, Burger HR, Zellweger U (1990) Phenprocoumon-induzierte cholestatische Hepatitis. Dtsch Med Wochenschr 120:1507–1510

    Article  Google Scholar 

  • Wout JW van’t, Herrmann WA, Vries RA de, Stricker BHC (1994) Terbinafine-associated hepatic injury. J Hepatol 21:115–117

    Article  Google Scholar 

  • Wright R (1981) Drug-induced chronic hepatitis. Springer Semin Immunopathol 3:331–338

    Article  Google Scholar 

  • Yanoff M, Rawson AJ (1964) Peliosis hepatis. An anatomical study with demonstration of two varieties. Arch Pathol 77:159–165

    PubMed  CAS  Google Scholar 

  • Zafrani ES, Berthelot P (1982) Sodium valporate in the induction of unusual hepatotoxicity. Hepatology 2:648–649

    Article  PubMed  CAS  Google Scholar 

  • Zafrani ES, Ishak KG, Rudzki C (1979) Cholestatic hepatocellular injury associated with erythromycin esters. Report of nine cases. Dig Dis Sci 24:385–396

    Article  PubMed  CAS  Google Scholar 

  • Zafrani ES, Pinaudeau Y, Dhumeaux D (1983) Drug induced vascular lesions of the liver. Arch Intern Med 143:495–502

    Article  PubMed  CAS  Google Scholar 

  • Zafrani ES, Bernuau D, Feldmann G (1984) Peliosis-like ultrastructural changes of the hepatic sinusoids in human chronic hypervitaminosis A. Hum Pathol 15:1166–1170

    Article  PubMed  CAS  Google Scholar 

  • Zala G, Schmid M, Bühler H (1993) Fulminante Hepatitis durch Disulfiram. Dtsch Med Wochenschr 118:1355–1360

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman HJ (1978) Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. Appleton Century Crofts, New York

    Google Scholar 

  • Zimmerman HJ (1986) Hepatotoxic effects of oncotherapeutic agents. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol VIII. Grune & Stratton, Orlando, pp 621–642

    Google Scholar 

  • Zimmermann H, Eck H (1975) Zur pathologischen Anatomie der Vinylchlorid-Krankheit. Virchows Arch A 368:51–59

    CAS  Google Scholar 

  • Zimmerman HJ, Ishak KG (1982) Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2:591–597

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Klinge, O. (2000). Toxische Hepatosen. In: Pathologie der Leber und Gallenwege. Spezielle pathologische Anatomie, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57036-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57036-0_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65511-4

  • Online ISBN: 978-3-642-57036-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics